383 related articles for article (PubMed ID: 15240872)
21. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Marrone A; Dokal I
Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
[TBL] [Abstract][Full Text] [Related]
22. Dyskerin is a component of the Arabidopsis telomerase RNP required for telomere maintenance.
Kannan K; Nelson AD; Shippen DE
Mol Cell Biol; 2008 Apr; 28(7):2332-41. PubMed ID: 18212040
[TBL] [Abstract][Full Text] [Related]
23. Single-molecule analysis of the human telomerase RNA.dyskerin interaction and the effect of dyskeratosis congenita mutations.
Ashbridge B; Orte A; Yeoman JA; Kirwan M; Vulliamy T; Dokal I; Klenerman D; Balasubramanian S
Biochemistry; 2009 Nov; 48(46):10858-65. PubMed ID: 19835419
[TBL] [Abstract][Full Text] [Related]
24. Dyskeratosis congenita mutations in the H/ACA domain of human telomerase RNA affect its assembly into a pre-RNP.
Trahan C; Dragon F
RNA; 2009 Feb; 15(2):235-43. PubMed ID: 19095616
[TBL] [Abstract][Full Text] [Related]
25. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
de la Fuente J; Dokal I
Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679
[TBL] [Abstract][Full Text] [Related]
26. Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer.
Montanaro L; Brigotti M; Clohessy J; Barbieri S; Ceccarelli C; Santini D; Taffurelli M; Calienni M; Teruya-Feldstein J; Trerè D; Pandolfi PP; Derenzini M
J Pathol; 2006 Sep; 210(1):10-8. PubMed ID: 16841302
[TBL] [Abstract][Full Text] [Related]
27. Human dyskerin: beyond telomeres.
Angrisani A; Vicidomini R; Turano M; Furia M
Biol Chem; 2014 Jun; 395(6):593-610. PubMed ID: 24468621
[TBL] [Abstract][Full Text] [Related]
28. RNA-guided isomerization of uridine to pseudouridine--pseudouridylation.
Yu YT; Meier UT
RNA Biol; 2014; 11(12):1483-94. PubMed ID: 25590339
[TBL] [Abstract][Full Text] [Related]
29. Pseudouridylation defect due to
Balogh E; Chandler JC; Varga M; Tahoun M; Menyhárd DK; Schay G; Goncalves T; Hamar R; Légrádi R; Szekeres Á; Gribouval O; Kleta R; Stanescu H; Bockenhauer D; Kerti A; Williams H; Kinsler V; Di WL; Curtis D; Kolatsi-Joannou M; Hammid H; Szőcs A; Perczel K; Maka E; Toldi G; Sava F; Arrondel C; Kardos M; Fintha A; Hossain A; D'Arco F; Kaliakatsos M; Koeglmeier J; Mifsud W; Moosajee M; Faro A; Jávorszky E; Rudas G; Saied MH; Marzouk S; Kelen K; Götze J; Reusz G; Tulassay T; Dragon F; Mollet G; Motameny S; Thiele H; Dorval G; Nürnberg P; Perczel A; Szabó AJ; Long DA; Tomita K; Antignac C; Waters AM; Tory K
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15137-15147. PubMed ID: 32554502
[TBL] [Abstract][Full Text] [Related]
30. GSE4, a Small Dyskerin- and GSE24.2-Related Peptide, Induces Telomerase Activity, Cell Proliferation and Reduces DNA Damage, Oxidative Stress and Cell Senescence in Dyskerin Mutant Cells.
Iarriccio L; Manguán-García C; Pintado-Berninches L; Mancheño JM; Molina A; Perona R; Sastre L
PLoS One; 2015; 10(11):e0142980. PubMed ID: 26571381
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution of archaeal H/ACA small ribonucleoprotein complexes active in pseudouridylation.
Charpentier B; Muller S; Branlant C
Nucleic Acids Res; 2005; 33(10):3133-44. PubMed ID: 15933208
[TBL] [Abstract][Full Text] [Related]
32. Dyskerin Mutations Present in Dyskeratosis Congenita Patients Increase Oxidative Stress and DNA Damage Signalling in
Rodriguez-Centeno J; Perona R; Sastre L
Cells; 2019 Nov; 8(11):. PubMed ID: 31717312
[TBL] [Abstract][Full Text] [Related]
33. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.
Parry EM; Alder JK; Lee SS; Phillips JA; Loyd JE; Duggal P; Armanios M
J Med Genet; 2011 May; 48(5):327-33. PubMed ID: 21415081
[TBL] [Abstract][Full Text] [Related]
34. Anomalous electrophoretic migration of newly synthesized ribosomal RNAs and their precursors from cells with DKC1 mutations.
Gu BW; Zhao C; Fan JM; Dai Q; Bessler M; Mason PJ
FEBS Lett; 2009 Sep; 583(18):3086-90. PubMed ID: 19729012
[TBL] [Abstract][Full Text] [Related]
35. Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.
Cerone MA; Ward RJ; Londoño-Vallejo JA; Autexier C
Cell Cycle; 2005 Apr; 4(4):585-9. PubMed ID: 15753647
[TBL] [Abstract][Full Text] [Related]
36. Relationship between dyskerin expression and telomerase activity in human breast cancer.
Montanaro L; Calienni M; Ceccarelli C; Santini D; Taffurelli M; Pileri S; Treré D; Derenzini M
Cell Oncol; 2008; 30(6):483-90. PubMed ID: 18936525
[TBL] [Abstract][Full Text] [Related]
37. Dyskerin ablation in mouse liver inhibits rRNA processing and cell division.
Ge J; Rudnick DA; He J; Crimmins DL; Ladenson JH; Bessler M; Mason PJ
Mol Cell Biol; 2010 Jan; 30(2):413-22. PubMed ID: 19917719
[TBL] [Abstract][Full Text] [Related]
38. Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA.
Zebarjadian Y; King T; Fournier MJ; Clarke L; Carbon J
Mol Cell Biol; 1999 Nov; 19(11):7461-72. PubMed ID: 10523634
[TBL] [Abstract][Full Text] [Related]
39. A new human dyskerin isoform with cytoplasmic localization.
Angrisani A; Turano M; Paparo L; Di Mauro C; Furia M
Biochim Biophys Acta; 2011 Dec; 1810(12):1361-8. PubMed ID: 21820037
[TBL] [Abstract][Full Text] [Related]
40. Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer.
Montanaro L
J Pathol; 2010 Dec; 222(4):345-9. PubMed ID: 20925138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
